Kala Bio (KALA) Share-based Compensation (2016 - 2026)
Kala Bio (KALA) reported Share-based Compensation of $1.76 million for Q1 2026, down 24.0% from $2.31 million a year earlier but up 337.7% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Share-based Compensation (2016 - 2026) Analysis & Trends
For FY2025, Kala Bio posted Share-based Compensation of $7 million, down 16.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $8.39 million in FY2024 (+12.4%), $7.46 million in FY2023 (+6.5%), $7.01 million in FY2022 (-56.4%) and $16.09 million in FY2021 (+20.9%).
- Five-year quarterly Share-based Compensation spans a low of $401,000 in Q4 2025 and a high of $4.71 million in Q2 2021.
- Year over year, Share-based Compensation gained in three of the last eight quarters, with an average decline of 9.6%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2023 (growth of 147.3%); the low point was Q4 2025 (a decline of 80.9%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $401,000 (Q4 2025), $2.04 million (Q3 2025) and $2.24 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 401,000.00 |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.32 Mn |
| Dec 31, 2022 | 960,000.00 |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 2.81 Mn |
| Dec 31, 2021 | 2.75 Mn |
| Sep 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 4.71 Mn |
API Access
Kala Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();